| Similar Articles |
|---|
 |
The Motley Fool
July 12, 2005
Tom Taulli |
IMS Health Goes Dutch Netherlands-based VNU NV seeks synergies by buying the health care data company. This purchase looks good on paper. That said, investors shouldn't expect immediate results.   |
BusinessWeek
June 25, 2007
Catherine Arnst |
IMS Health: Where The Best Medicine Is Data Drugmakers have come to rely on the company's inside track on the prescriptions doctors write. |
Managed Care
May 2004 |
Biologics Among Fastest Growers Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs. |
The Motley Fool
October 10, 2006
Tom Taulli |
NetRatings Gets the Low Bid VNU controls NetRatings and, as a result, wants to make sure it gets a good price on the buyout. Unfortunately, getting a low bid is always the risk for public companies that are controlled by a parent company. Investors, take note. |
The Motley Fool
March 15, 2007
Brian Lawler |
It's All Good for Drugmakers With the whole drug industry growing so strongly, those looking for a safe place to park their investing dollars would be smart to take a look at some of the largest generic drugmakers. |
